Some clinicians report benefit from psychostimulant for depression in patients with short life expectancy. However, we do not recommend the use of psychostimulants due to there being strong evidence of adverse effects and inadequate evidence of efficacy. For patients with short prognosis, the threshold for treatment resistant depression should be lowered from 6 weeks to 4 weeks.